Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 20;12(1):2269634.
doi: 10.1080/2162402X.2023.2269634. eCollection 2023.

CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis

Affiliations

CD4+ T cell-derived IL-22 enhances liver metastasis by promoting angiogenesis

Tao Zhang et al. Oncoimmunology. .

Abstract

Metastasis is a cancer-related systemic disease and is responsible for the greatest mortality rate among cancer patients. Interestingly, the interaction between the immune system and cancer cells seems to play a key role in metastasis formation in the target organ. However, this complex network is only partially understood. We previously found that IL-22 produced by tissue resident iNKT17 cells promotes cancer cell extravasation, the early step of metastasis. Based on these data, we aimed here to decipher the role of IL-22 in the last step of metastasis formation. We found that IL-22 levels were increased in established metastatic sites in both human and mouse. We also found that Th22 cells were the key source of IL-22 in established metastasis sites, and that deletion of IL-22 in CD4+ T cells was protective in liver metastasis formation. Accordingly, the administration of a murine IL-22 neutralizing antibody in the establishment of metastasis formation significantly reduced the metastatic burden in a mouse model. Mechanistically, IL-22-producing Th22 cells promoted angiogenesis in established metastasis sites. In conclusion, our findings highlight that IL-22 is equally as important in contributing to metastasis formation at late metastatic stages, and thus, identify it as a novel therapeutic target in established metastasis.

Keywords: IL-22; Th22; liver metastasis.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Increased IL-22 levels in human liver metastasis.
Figure 2.
Figure 2.
Th22 cells are the main source of IL-22 in murine-established liver metastasis.
Figure 3.
Figure 3.
Th22 cells are the main source of IL-22 in established murine lung metastasis.
Figure 4.
Figure 4.
Lin- cells are not the main source of IL-22 in established murine liver metastasis.
Figure 5.
Figure 5.
Lin- cells are not the main source of IL-22 in established murine lung metastasis.
Figure 6.
Figure 6.
T cell- but not Th17-derived IL-22 plays a key role in liver and lung metastasis formation.
Figure 7.
Figure 7.
IL-22 promotes angiogenesis in established liver metastasis.

References

    1. Garner H, de Visser KE.. Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nat Rev Immunol. 2020;20(8):483–12. doi: 10.1038/s41577-019-0271-z. - DOI - PubMed
    1. Blomberg OS, Spagnuolo L, de Visser KE.. Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Dis Model Mech. 2018;11(10):dmm036236. doi: 10.1242/dmm.036236. - DOI - PMC - PubMed
    1. Lan Q, Lai W, Zeng Y, Liu L, Li S, Jin S, Zhang Y, Luo X, Xu H, Lin X, et al. CCL26 participates in the PRL-3–induced promotion of colorectal cancer invasion by stimulating tumor-associated macrophage infiltration. Mol Cancer Ther. 2018;17(1):276–289. doi: 10.1158/1535-7163.MCT-17-0507. - DOI - PubMed
    1. Ganesh K, Massague J. Targeting metastatic cancer. Nat Med. 2021;27(1):34–44. doi: 10.1038/s41591-020-01195-4. - DOI - PMC - PubMed
    1. Gomez-Cuadrado L, Tracey N, Ma R, Qian B, Brunton VG. Mouse models of metastasis: progress and prospects. Dis Model Mech. 2017;10(9):1061–1074. doi: 10.1242/dmm.030403. - DOI - PMC - PubMed